LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹152 Cr | ₹119 Cr | ₹122 Cr | ₹104 Cr | ₹103 Cr |
What is the latest Contingent Liabilities ratio of LAURUS LABS ?
Year | Contingent Liabilities |
---|---|
Mar2023 | ₹152 Cr |
Mar2022 | ₹119 Cr |
Mar2021 | ₹122 Cr |
Mar2020 | ₹104 Cr |
Mar2019 | ₹103 Cr |
How is Contingent Liabilities of LAURUS LABS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹152 Cr | 28.14 | |
Mar2022 | ₹119 Cr | -2.33 | |
Mar2021 | ₹122 Cr | 17.23 | |
Mar2020 | ₹104 Cr | 0.93 | |
Mar2019 | ₹103 Cr | - |
Compare Contingent Liabilities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹23,645.9 Cr | -1.1% | 5.7% | 43.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹367,026.0 Cr | 0.5% | -5.7% | 55.1% | Stock Analytics | |
CIPLA | ₹114,925.0 Cr | 1.1% | -4.4% | 55.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,128.0 Cr | -0.7% | 9.4% | 21.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,109.0 Cr | 0.1% | 1.1% | 28.1% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,736.0 Cr | 6% | 2.8% | 93.1% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | -1.1% |
5.7% |
43.8% |
SENSEX | 0.2% |
-0.2% |
20.9% |
You may also like the below Video Courses